TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD

Tianjin Chase Sun Pharmaceutical Co.,Ltd

300026

CNE100000GF1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
3.73 ^CNY	+0.54%		+0.54%	-12.03%

Mar. 29	Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Final Dividend for 2023	CI
Mar. 01	Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue	MT

Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces the Election of Li Li as an Independent Director

November 19, 2020 at 02:47 pm EST

Tianjin Chase Sun Pharmaceutical Co.,Ltd announced the election of Li Li as an independent director.

Latest news about Tianjin Chase Sun Pharmaceutical Co.,Ltd

Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Final Dividend for 2023	Mar. 28	CI
Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue	Feb. 29	MT
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Tianjin Chase Sun Pharma’s Muscle Relaxant Passes Drug Consistency Test	23-09-22	MT
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd. Approves Final Cash Dividend for A Shares for the Year 2022, Payable on 12 May 2023	23-05-08	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2022	23-04-25	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Profit Distribution Proposal for 2022	23-03-31	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2021, Payable on May 19, 2022	22-05-12	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2021	22-04-22	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Cash Dividend for 2021	22-03-31	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Final Dividend on A Shares for the Year 2020, Payable on June 10, 2021	21-06-04	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Cash Dividend for 2020	21-05-19	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Profit Distribution Proposal for 2020	21-03-31	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI

Chart Tianjin Chase Sun Pharmaceutical Co.,Ltd

Duration

Period

Chart Tianjin Chase Sun Pharmaceutical Co.,Ltd

More charts

Tianjin Chase Sun Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and distribution of pharmaceuticals. The Company's main products include Chinese traditional formula granules, Xuebijing injection, fasudil hydrochloride injection, low molecular weight heparin calcium injection, bulk drugs and excipient, among others. The Company also provides medical apparatus and instrument. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-04-25 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Tianjin Chase Sun Pharmaceutical Co.,Ltd

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.73 CNY

Average target price

4 CNY

Spread / Average Target

+7.24%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.03%	1.54B
DONG-E-E-JIAO CO.,LTD.	+37.37%	6.05B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.69%	4.45B
TASLY PHARMACEUTICAL GROUP CO., LTD	-12.46%	3.06B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.12%	3.04B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+0.47%	2.58B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+36.06%	1.79B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.84%	1.66B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-10.60%	1.63B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+36.40%	1.42B

Alternative Medicine